IR@PKUHSC  > 北京大学第二临床医学院  > 妇科肿瘤中心
学科主题临床医学
PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer
Ma, Ruiqiong; Ye, Xue; Cheng, Hongyan; Ma, Yu; Cui, Heng; Chang, Xiaohong
关键词Epithelial Ovarian Cancer Prss3 Survival Prognostic Marker
刊名GYNECOLOGIC ONCOLOGY
2015-06-01
DOI10.1016/j.ygyno.2015.02.022
137期:3页:546-552
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology ; Obstetrics & Gynecology
研究领域[WOS]Oncology ; Obstetrics & Gynecology
关键词[WOS]PROTEASE-ACTIVATED RECEPTOR-2 ; INHIBITOR RESISTANCE ; CELL-PROLIFERATION ; TRYPSIN-INHIBITOR ; HUMAN MESOTRYPSIN ; BREAST-CANCER ; COLON-CANCER ; METASTASIS ; GROWTH ; BRAIN
英文摘要

Objective. PRSS3 is an atypical isoform of trypsin that has been associated with breast, lung, and pancreatic cancers. This study aimed to elucidate the role of PRSS3 in tumor tissues of patients with epithelial ovarian cancer (EOC) and to investigate the prognostic value of this marker.

Methods. PRSS3 expression was evaluated by immunohistochemistry and real-time PCR (RT-PCR) in ovarian cancers, benign ovarian tumors and the ovaries of age-matched normal patients. Correlations between clinicopathologic variables and PRSS3 expression in EOC tissues and the prognostic value of PRSS3 for progression-free survival (PFS) and overall survival (OS) were evaluated.

Results. PRSS3 expression was significantly elevated in EOC tissues compared to benign ovarian tumors and normal ovarian controls at both the mRNA and protein levels. There was a good correlation between the PRSS3 expression levels measured by the two different techniques. High PRSS3 expression in EOC tissues was significantly associated with advanced FIGO stage and lymph node metastasis. In a univariate survival analysis of the ovarian carcinoma cohort, positive expression of PRSS3 was significantly associated with shortened patient survival. Importantly, PRSS3 expression was a significant independent prognostic parameter in the multivariate analysis.

Conclusions. These findings indicate that PRSS3 overexpression can be used as a predictor of clinical outcome in patients with ovarian cancer and may therefore represent a new prognostic marker. (C) 2015 Elsevier Inc. All rights reserved.

语种英语
WOS记录号WOS:000355779000030
引用统计
被引频次:9[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/50578
专题北京大学第二临床医学院_妇科肿瘤中心
作者单位Peking Univ, Peoples Hosp, Gynecol Oncol Ctr, Beijing 100044, Peoples R China
推荐引用方式
GB/T 7714
Ma, Ruiqiong,Ye, Xue,Cheng, Hongyan,et al. PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer[J]. GYNECOLOGIC ONCOLOGY,2015,137(3):546-552.
APA Ma, Ruiqiong,Ye, Xue,Cheng, Hongyan,Ma, Yu,Cui, Heng,&Chang, Xiaohong.(2015).PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer.GYNECOLOGIC ONCOLOGY,137(3),546-552.
MLA Ma, Ruiqiong,et al."PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer".GYNECOLOGIC ONCOLOGY 137.3(2015):546-552.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Ma, Ruiqiong]的文章
[Ye, Xue]的文章
[Cheng, Hongyan]的文章
百度学术
百度学术中相似的文章
[Ma, Ruiqiong]的文章
[Ye, Xue]的文章
[Cheng, Hongyan]的文章
必应学术
必应学术中相似的文章
[Ma, Ruiqiong]的文章
[Ye, Xue]的文章
[Cheng, Hongyan]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。